Supercharge Cellular Energy Metabolism
A pineal‑derived peptide that activates telomerase and rewires metabolic pathways for healthier cells.
Epithalon (also called epialen) is a short tetrapeptide released by the pineal gland. Dr. Jason Schuster explains that it can lengthen telomeres, improve mitochondrial function, and modulate lipid and glucose metabolism, making it a promising tool for metabolic health.
A Pineal‑Gland Tetrapeptide
Epithalon (also written as epialen, epialamin or epialin) is a four‑amino‑acid peptide—alanine, glutamine, aspartic acid and glycine—naturally secreted by the pineal gland. Dr. Schuster notes that it is one of the few unilateral structures in the brain and that the peptide is used in anti‑aging protocols because of its impact on telomere biology.
- Alanine‑Glutamine‑Aspartic‑Glycine (A‑Q‑D‑G)
- Derived from the pineal gland’s secretome
- Classified as a short peptide (tetrapeptide)
How It Talks to Your DNA
According to Dr. Schuster, Epithalon up‑regulates the expression of telomerase (the enzyme that adds repeats to chromosome ends), thereby lengthening telomeres and extending cellular replicative capacity. It also increases GAP‑43 and nestin proteins, promotes neuronal differentiation, and influences histone‑DNA interactions, lipid‑chaperone activity, and melatonin synthesis. These actions collectively improve mitochondrial health and cellular energy production.
- Stimulates telomerase → longer telomeres
- Boosts GAP‑43 and nestin → neuronal growth
- Modulates histone‑DNA binding
- Enhances intracellular lipid chaperones → better lipid trafficking
- Raises melatonin synthesis via pineal support
Metabolic and Anti‑Aging Effects
Dr. Schuster lists multiple downstream effects: improved insulin resistance, balanced triglyceride and lipoprotein metabolism, increased fatty‑acid oxidation, reduced chronic inflammation, and enhanced vascular function. Longer telomeres, better mitochondrial performance, and optimized pineal activity translate into a broader health‑span benefit, including potential neuroprotection and reduced tumor risk.
- Improves insulin sensitivity
- Optimizes triglyceride and lipoprotein handling
- Increases fatty‑acid oxidation and energy output
- Reduces chronic inflammation
- Supports pineal gland and melatonin production
- May lower cancer risk through anti‑inflammatory action
Typical Clinical Protocol
In the video Dr. Schuster describes a low‑frequency regimen that differs from more frequently dosed peptides. A common protocol uses 10 mg of Epithalon in 2 mL of saline administered every three days (≈5 injections per course, 50 mg total). Six such courses over three years—often spaced six months apart—amount to a cumulative 300 mg, and the cycle can be repeated semi‑annually to annually. He emphasizes the safety profile as “very, very safe” with no serious adverse events reported.
- 10 mg in 2 mL saline per injection
- One injection every 3 days (≈5 injections per course)
- Six courses over 3 years (≈300 mg total)
- Repeat each 6–12 months
- Reportedly well‑tolerated with minimal side effects
“Epithalon stimulates telomerase, lengthening telomeres and essentially turning back the cellular clock.”— Dr. Jason Schuster
Go deeper than the summary
Dr. Schuster's board-certified, accredited peptide therapy courses — the full research, dosing, and video breakdowns.